ACADIA Pharmaceuticals Statistics

Total Valuation

LON:0A4W has a market cap or net worth of GBP 2.16 billion. The enterprise value is 1.62 billion.

Market Cap	2.16B
Enterprise Value	1.62B

Important Dates

The last earnings date was Thursday, February 27, 2025.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.55%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	114.39M

Valuation Ratios

The trailing PE ratio is 11.95.

PE Ratio	11.95
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	4.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.01, with an EV/FCF ratio of 12.89.

EV / Earnings	8.95
EV / Sales	2.19
EV / EBITDA	19.01
EV / EBIT	24.85
EV / FCF	12.89

Financial Position

The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.07.

Current Ratio	2.38
Quick Ratio	2.18
Debt / Equity	0.07
Debt / EBITDA	0.47
Debt / FCF	0.33
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 38.89% and return on invested capital (ROIC) is 8.27%.

Return on Equity (ROE)	38.89%
Return on Assets (ROA)	5.44%
Return on Invested Capital (ROIC)	8.27%
Return on Capital Employed (ROCE)	10.63%
Revenue Per Employee	1.17M
Profits Per Employee	276,578
Employee Count	654
Asset Turnover	0.99
Inventory Turnover	13.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.17%
50-Day Moving Average	17.41
200-Day Moving Average	16.42
Relative Strength Index (RSI)	58.25
Average Volume (20 Days)	2,167

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.66

Income Statement

In the last 12 months, LON:0A4W had revenue of GBP 765.06 million and earned 180.88 million in profits. Earnings per share was 1.09.

Revenue	765.06M
Gross Profit	457.46M
Operating Income	67.32M
Pretax Income	206.14M
Net Income	180.88M
EBITDA	80.01M
EBIT	67.32M
Earnings Per Share (EPS)	1.09

Full Income Statement

Balance Sheet

The company has 603.86 million in cash and 41.53 million in debt, giving a net cash position of 562.33 million.

Cash & Cash Equivalents	603.86M
Total Debt	41.53M
Net Cash	562.33M
Net Cash Per Share	n/a
Equity (Book Value)	585.33M
Book Value Per Share	3.51
Working Capital	434.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 125.98 million and capital expenditures -417,757, giving a free cash flow of 125.56 million.

Operating Cash Flow	125.98M
Capital Expenditures	-417,757
Free Cash Flow	125.56M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.79%, with operating and profit margins of 8.80% and 23.64%.

Gross Margin	59.79%
Operating Margin	8.80%
Pretax Margin	26.94%
Profit Margin	23.64%
EBITDA Margin	10.46%
EBIT Margin	8.80%
FCF Margin	16.41%

Dividends & Yields

LON:0A4W does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.55%
Shareholder Yield	-1.55%
Earnings Yield	8.37%
FCF Yield	5.81%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0A4W has an Altman Z-Score of 2.99. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.99
Piotroski F-Score	n/a